Pediatrix eliminates EVP role of Lee Wood; departure by July 5, 2024

Pediatrix Medical Group, Inc.

Lee A. Wood's role as EVP of National and Market Operations eliminated effective July 5, 2024.
Termination is without cause under second amended employment agreement dated April 2023.
Departure part of company's previously announced continued focus on operating efficiency.
No replacement named; the role is eliminated as part of restructuring.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Lee A. Wood

Executive Vice President, National and Market Operations

MD · Pediatrix Medical Group, Inc.

Effective: 2024-07-05
Filed: June 17, 2024, 7:59 PM ET

On June 17, 2024, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), notified Mr. Lee. A Wood that the Company was eliminating the role of Executive Vice President, National and Market Operations, effective as of July 5, 2024 (the “Effective Date”), as part of the Company’s previously announced continued focus on operating efficiency.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Lee A. Wood departed as Executive Vice President, National and Market Operations at Pediatrix Medical Group, Inc..

Action: departed
Role: Executive Vice President, National and Market Operations

Exact text from the filing

On June 17, 2024, Pediatrix Medical Group, Inc., a Florida corporation (the “Company”), notified Mr. Lee. A Wood that the Company was eliminating the role of Executive Vice President, National and Market Operations, effective as of July 5, 2024 (the “Effective Date”), as part of the Company’s previously announced continued focus on operating efficiency.

View on SEC.gov

Pediatrix Medical Group, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-24-074283

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.